Hemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsMino-WrapWe haveenough cashto go wellinto 2023Not manycompaniesthis size with2 late stageassetsI won't diluteshareholdersI'm ashareholdermyselfI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Only biotechwith 2 Myron'son theleadershipteamWe will openupinternationalsites forMino-Lok trialAn actualiMSCupdateWe had aphase 2btrial with100%efficacyWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022We expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI/ONTAKis our leadassetInsidersinvested$26.5mWe willhaveexclusivityMino-Lokis our leadassetHemorrhoidsis a $2BmarketThere are noFDAapproveddrugs to treathemorrhoidsMino-WrapWe haveenough cashto go wellinto 2023Not manycompaniesthis size with2 late stageassetsI won't diluteshareholdersI'm ashareholdermyselfI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Only biotechwith 2 Myron'son theleadershipteamWe will openupinternationalsites forMino-Lok trialAn actualiMSCupdateWe had aphase 2btrial with100%efficacyWe intendto submita BLA in2H 2022Mino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022We expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"I/ONTAKwas thebest deal Iever madeI/ONTAK'spotentialmarket is>$300mI/ONTAKis our leadassetInsidersinvested$26.5mWe willhaveexclusivityMino-Lokis our leadasset

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Hemorrhoids is a $2B market
  2. There are no FDA approved drugs to treat hemorrhoids
  3. Mino-Wrap
  4. We have enough cash to go well into 2023
  5. Not many companies this size with 2 late stage assets
  6. I won't dilute shareholders
  7. I'm a shareholder myself
  8. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  9. Only biotech with 2 Myron's on the leadership team
  10. We will open up international sites for Mino-Lok trial
  11. An actual iMSC update
  12. We had a phase 2b trial with 100% efficacy
  13. We intend to submit a BLA in 2H 2022
  14. Mino-Lok potential market >$1B
  15. Our Halo-Lido trial will have final patient by end of 2022
  16. We expect to finish the Mino-Lok trial this year
  17. Myron Holubiak and I founded a private company in 2013
  18. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  19. I/ONTAK was the best deal I ever made
  20. I/ONTAK's potential market is >$300m
  21. I/ONTAK is our lead asset
  22. Insiders invested $26.5m
  23. We will have exclusivity
  24. Mino-Lok is our lead asset